Satoshi Hirooka Selected Research

A 19

1/2014

Less morbidity after introduction of a new departmental policy for patients who undergo open distal pancreatectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Hirooka Research Topics

Disease

14	Adenocarcinoma 01/2023 - 04/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 11/2010
10	Neoplasms (Cancer) 06/2022 - 01/2008
6	Pancreatic Fistula (Pancreatic Fistulas) 01/2019 - 01/2011
5	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2011
3	Cholangitis 11/2022 - 01/2014
3	Cholelithiasis 01/2020 - 01/2019
2	Lymphatic Metastasis 06/2022 - 05/2020
2	Non-alcoholic Fatty Liver Disease 03/2016 - 03/2014
1	Taste Disorders (Taste Disorder) 01/2023
1	Anemia 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Neoplasms, Cystic, Mucinous, and Serous 11/2022
1	Pathologic Constriction (Stenosis) 11/2022
1	Cholecystolithiasis 01/2020
1	Gallbladder Diseases (Gall Bladder Disease) 04/2019
1	Edema (Dropsy) 04/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Acute Cholecystitis 04/2019
1	Pancreatitis 04/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Infections 01/2018
1	Ascites 01/2017
1	Diarrhea 01/2017
1	Median Arcuate Ligament Syndrome 12/2016
1	Fatigue 01/2016
1	Neutropenia 01/2016
1	Abdominal Abscess 01/2014
1	Cysts 11/2013
1	Fibrosis (Cirrhosis) 02/2013

Drug/Important Bio-Agent (IBA)

3	CarbohydratesIBA 02/2022 - 04/2011
3	Gemcitabine FDA Link 05/2017 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 05/2017
2	Active Hexose Correlated CompoundIBA 11/2021 - 01/2016
2	AntigensIBA 07/2021 - 04/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2014
2	EnzymesIBA 03/2016 - 03/2014
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 02/2013
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	CytokinesIBA 04/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Perilipin-2IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	folfirinoxIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 09/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 08/2014
1	Losartan (Cozaar)FDA LinkGeneric 08/2014
1	Angiotensin IIIBA 08/2014
1	A 19IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2011
1	Polyglycolic Acid (Polyglycolide)IBA 01/2011
1	Prostaglandins AIBA 01/2011
1	Serum AlbuminIBA 01/2008

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2023 - 02/2013
8	Pancreaticoduodenectomy 11/2022 - 01/2014
7	Pancreatectomy 11/2022 - 04/2012
5	Therapeutics 05/2017 - 11/2010
4	Neoadjuvant Therapy 11/2021 - 11/2010
3	Adjuvant Chemotherapy 06/2022 - 01/2017
3	Cholecystectomy 01/2020 - 01/2019
2	Laparotomy 03/2022 - 04/2011
2	Laparoscopic Cholecystectomy 01/2019 - 01/2018
2	Pancreaticojejunostomy 01/2019 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2016
2	Length of Stay 01/2019 - 01/2014
1	Lymph Node Excision (Lymph Node Dissection) 01/2023
1	Preoperative Period 11/2022
1	Jejunostomy 11/2022
1	Combined Modality Therapy 05/2020
1	Chemoradiotherapy 05/2020
1	Aftercare (After-Treatment) 02/2013